ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
about
Darolutamide (ODM-201) for the treatment of prostate cancerAndrogen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer: Qualitative Study Findings.Enzalutamide induced acute generalized exanthematous pustulosis.Editorial Comment to Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.Recent Advances in Prostate Cancer Treatment and Drug Discovery.
P2860
ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@ast
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@en
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@nl
type
label
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@ast
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@en
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@nl
prefLabel
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@ast
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@en
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@nl
P2093
P2860
P921
P1476
ODM-201: a new-generation andr ...... tion-resistant prostate cancer
@en
P2093
Christophe Massard
Laurence Albiges
Yohann Loriot
P2860
P304
P356
10.1586/14737140.2015.1081566
P407
P577
2015-01-01T00:00:00Z